Interleukin-1beta Induces Macrophage Inflammatory Protein-1beta Expression in Human Hepatocytes
Overview
Cell Biology
Affiliations
The investigation of factors that regulate expression of CC-chemokines, the important mediators in immune responses and inflammation processes, has an important significance in understanding the immunopathogenesis of liver diseases. We examined the role of interleukin-1beta (IL-1beta), a multifunctional cytokine, in regulating the expression of macrophage inflammatory protein (MIP)-1beta in human hepatocytes (Huh7 and HepG2). IL-1beta significantly enhanced MIP-1beta expression in these cells at both the mRNA and protein levels. Cytokine-enriched supernatants from monocyte-derived macrophage (MDM) cultures also induced MIP-1beta expression. IL-1beta is responsible for MDM supernatant-mediated up-regulation of MIP-1beta since the antibody to IL-1beta abolished MDM supernatant action. Investigation of the mechanism involved in MIP-1beta induction by IL-1beta showed that IL-1beta activated the nuclear factor kappa B (NF-kappaB) promoter in Huh7 cells. In addition, caffeic acid phenethyl ester (CAPE), a specific inhibitor of the activation of NF-kappaB, not only abolished IL-1beta-mediated NF-kappaB promoter activation, but also blocked IL-1beta-induced MIP-1beta expression. These observations suggest that IL-1beta-mediated up-regulation of MIP-1beta production in the hepatic cells may contribute a critical mechanism for continuous recruitment of inflammatory cell to liver and maintenance of inflammation.
Masyeni S, Kuntaman K, Aryati A, Sofro M, Hadi U, Mastutik G Narra J. 2024; 3(2):e167.
PMID: 38454980 PMC: 10919718. DOI: 10.52225/narra.v3i2.167.
Golfetto Miskiewicz I, Cho H, Lee J, Lee J, Lee Y, Lee Y FEBS Open Bio. 2023; 13(4):606-616.
PMID: 36637998 PMC: 10068306. DOI: 10.1002/2211-5463.13552.
Liao T, Huang J, Tsai Y, Shih W, Juan C, Hsieh P Int J Mol Sci. 2022; 23(21).
PMID: 36361830 PMC: 9656569. DOI: 10.3390/ijms232113048.
Wang Y, Zhang Y, Li Y, Liu Y, Liu Y Front Cell Dev Biol. 2022; 10:946566.
PMID: 36211451 PMC: 9533023. DOI: 10.3389/fcell.2022.946566.
Discovery of 5-Aryl-2,4-diaminopyrimidine Compounds as Potent and Selective IRAK4 Inhibitors.
Chen Y, Singh R, Lin N, Taylor V, Masuda E, Payan D ACS Med Chem Lett. 2022; 13(4):714-719.
PMID: 35450353 PMC: 9014513. DOI: 10.1021/acsmedchemlett.2c00056.